Vioxx expected to drag on Merck 2005 and play key role in 2006 performance

Vioxx expected to drag on Merck 2005 and play key role in 2006 performance: "Vioxx is expected to drag down Merck & Co.'s 2005 earnings when they are reported Tuesday. But what's really frustrating analysts is their inability to assess the drug's potential liability and the toll that litigation preparations are taking on the company." [Canoe Money]